3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
2
Adenocarcinoma
2
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Recurrence
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Malignant Liver Neoplasm
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Eyelid Squamous Cell Carcinoma
1
Cholangiocarcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Taxes
1
Standard of Care
1
Panitumumab
1
Pancreaticoduodenectomy
1
Optical Imaging
1
Losartan
1
Gemcitabine
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Adenocarcinoma
×
Radiotherapy, Image-Guided
×
90 days
×
Clear all
No trials found.